TheStreet.com Ratings

Critical Illness vs. Cancer Policies: What's Best for You?

 

A recent study by the American Cancer Society shows women diagnosed with breast cancer have a better chance for survival than they have had in decades -- although African American women have benefited less.

That got me thinking about how my family and I would manage if we ever had to face a diagnosis of cancer -- or a heart attack or stroke for that matter. While the declining mortality rate for breast cancer is great news, the increased screenings and improved treatments that made it possible are expensive.

If my husband or I were ever to become ill, I wouldn't want to have to worry about having to tap into our retirement savings or our children's college fund to handle expenses my regular health insurance doesn't cover.

Supplemental Care

There are two types of policies that can plug the gap: those that cover a range of critical illnesses, including cancer, and those only covers a cancer diagnosis. I decided to check them both out to see which is better. My conclusion: a critical illness policy is a more flexible and easier to understand product than a cancer-only policy, but both are worth considering.

Both cancer and critical illness policies are meant to supplement your comprehensive health care policy and are usually sold through an arrangement with your employer. They are intended to cover medical costs above and beyond what your major medical policy will cover, such as experimental treatments or the policy deductibles and co-pays.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet